Los Angeles Capital Management’s Transmedics TMDX Stock Holding History

Los Angeles Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$456K	Sell	4,590 -20,970	-82%	-$2.74M	﹤0.01%	901
2025 Q4	$3.47M	Sell	25,560 -372	-1%	-$46.7K	0.01%	348
2025 Q3	$2.91M	Buy	25,932 +13,933	+116%	+$1.63M	0.01%	416
2025 Q2	$1.61M	Buy	+11,999	New	+$1.32M	0.01%	501
2024 Q4	–	Sell	-10,866	Closed	-$1.71M	–	1242
2024 Q3	$1.71M	Buy	10,866 +1,559	+17%	+$240K	0.01%	496
2024 Q2	$1.4M	Buy	9,307 +1,551	+20%	+$186K	0.01%	543
2024 Q1	$573K	Sell	7,756 -2,588	-25%	-$213K	﹤0.01%	833
2023 Q4	$816K	Buy	10,344 +2,219	+27%	+$134K	﹤0.01%	734
2023 Q3	$445K	Sell	8,125 -235	-3%	-$16.9K	﹤0.01%	847
2023 Q2	$702K	Buy	+8,360	New	+$640K	﹤0.01%	750

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Los Angeles Capital Management's TMDX Position: Q1 2026 in Review

Los Angeles Capital Management reduced its Transmedics (TMDX) stake by 82% in Q1 2026, selling an estimated $2.74M and leaving 4,590 shares worth $456K. The position accounts for ﹤0.01% of the portfolio, ranked #901.

Los Angeles Capital Management first reported a position in TMDX in Q2 2023 and has held it in 10 quarters since. The position peaked at $3.47M in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Los Angeles Capital Management held 4,590 shares of Transmedics worth $456K as of Q1 2026.
Los Angeles Capital Management sold 20,970 Transmedics shares in Q1 2026, an estimated $2.74M.
Transmedics made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #901 holding.
Los Angeles Capital Management first reported a position in Transmedics in Q2 2023 and has held it in 10 quarters since.
Los Angeles Capital Management's Transmedics position peaked at $3.47M in Q4 2025.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.